Q2 2026 Holdings
Filed 2026-08-14 | 23 holdings | $143.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $27.7M | 82,796 | 19.3% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $21.5M | 4,685,912 | 15.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $12.2M | 390,949 | 8.5% |
| Sutro Biopharma Inc(STRO) | COM | 869367201 | $9.0M | 270,251 | 6.3% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $7.6M | 218,694 | 5.3% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $6.8M | 507,801 | 4.7% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $6.5M | 92,745 | 4.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.2M | 532,481 | 3.6% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.9M | 265,199 | 3.4% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $4.5M | 173,395 | 3.1% |
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $4.4M | 4,705 | 3.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS ORD A | 61559X104 | $4.2M | 215,652 | 2.9% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $4.1M | 282,564 | 2.8% |
| Minerva Neurosciences(NERV) | COM NEW | 603380205 | $3.9M | 709,500 | 2.7% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $3.8M | 561,808 | 2.7% |
| Avalyn Pharma Inc(AVLN) | COM SHS | 05348Y105 | $3.8M | 115,000 | 2.6% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $3.4M | 186,308 | 2.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.0M | 168,115 | 2.1% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $2.5M | 260,416 | 1.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $1.3M | 595,213 | 0.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.2M | 2,224 | 0.8% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.0M | 63,095 | 0.7% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $938.6K | 28,919 | 0.7% |